Delivering the promise: Progress, challenges, opportunities

Hypertension

Volumn 51, Issue 6, 2008, Pages 1399-1402

  Jones, Daniel W ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY STENT; DIABETES MELLITUS; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY MONITORING; FIBRINOLYTIC THERAPY; HEALTH CARE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH INSURANCE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SECONDARY PREVENTION; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE;

EID: 57449119822     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.009956     Document Type: Conference Paper

References (15)

1. Gibbons R, Smith S, Antman E. American College of Cardiology/ American Heart Association clinical practice guidelines, part 1: where to they come from? Circulation. 2003;107:2979-2986.
2. Jacobs AK, Antman EM, Faxon DF, Gregory T, Solis P. Development of systems of care for ST-elevation myocardial infarction patients. Executive Summary. Circulation. 2007;116:217-230.
3. Fonarow GC, Ballantyne C. Inhospital initiation of lipid-lowering therapy for patients with coronary heart disease: the time is now. Circulation. 2001;103:2768-2770.
4. http://www.cdc.gov/DataStatistics/.
5. Marmont M. Status syndrome: a challenge to medicine. JAMA. 2006;295:1304 -1307.
6. Harper S, Lynch J, Burris S, Smith GD. Trends in the black-white life expectancy gap in the United States, 1983-2003. JAMA. 2007;297: 1224 -1232.
7. Karlamangla AS, Singer BH, Williams DR, Schwartz JE, Matthews KA, Kiefe CI, Seeman TE. Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: the CARDIA study (USA). Social Sci Med. 2005;60:999-1015.
8. Cappuccio FP, Kerry SM, Adeyemo A, Luke A, Amoah AG, Bovet P, Conner MD, Forrester T, Gervasoni JP, Kaki GK, Plange-Rhule J, Thorogood M, Cooper RS. Body size and blood pressure: an analysis of Africans and the African diaspora. Epidemiology. 2008;19:38-46.
9. http://www.thekingcenter.org/.
10. Gibbons RJ. Leading the elephant out of the corner: the future of health care: presidential address at the Am Heart Association 2006 scientific sessions. Circulation. 2007;115:2221-2230.
11. Alliance for a Healthier Generation.
12. Kearney PM, Welton M, Reynolds K, Munter P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365:217-223.
13. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2000;356:1955-1964.
14. Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey WJ, Taylor HA, Jones DW. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension. 2008;51:650-666.
15. Grothe K, Bouldin M, Valderrama R, et al. Reducing racial disparity in diabetic outcomes for the Mississippi Delta. Diabetes. 2007;56(S1):A312.